News Sentiment

BCAX sentiment intelligence

Bicara Therapeutics Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 62 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 27.76 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-4.0% over one week, +19.5% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Bicara Therapeutics (BCAX) Corporate presentation Summary

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction -4.0% Price reacting lower
Trend fit Trend active 19.5% over four weeks
Fair value 65.1% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 45
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
Stock Titan 8
Investing.com 5
TradingView 5
Quartr 4
Investing.com Nigeria 3
Motley Fool 3
GlobeNewswire 2

Event Lens

What the news is about

Classified themes
Market update 42
Earnings 19
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 62